News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Ciara Freeman: How soluble BCMA quantification and MTV from SOC PET can predict tumor burden
Ciara Freeman/X
Dec 15, 2024, 10:14

Ciara Freeman: How soluble BCMA quantification and MTV from SOC PET can predict tumor burden

Ciara Freeman, Assistant Member, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, shared on X:

“Excited to share our latest work in Blood Journal.

We demonstrate how soluble BCMA (sBCMA) quantification and MTV from SOC PET can predict tumor burden, response, and toxicity from CAR-T!

True multidisciplinary effort!”

Tumor burden quantified by Soluble B-Cell Maturation Antigen and Metabolic Tumor Volume determine myeloma CAR-T outcomes

Authors: Ciara L Freeman, Jerald Noble, Meghan Menges, Ricardo Villanueva, Justyn Y Nakashima, Nicholas B Figura, R. Petter Tonseth, Dietrich Werner Idiaquez, Lawrence Skelson, Eric C Smith, Julieta Abraham-Miranda, Salvatore Corallo, Gabriel De Avila, Omar Castaneda Puglianini, Hien D Liu, Melissa Alsina, Taiga Nishihori, Kenneth H Shain, Rachid C Baz, Brandon J Blue, Ariel Grajales-Cruz, John M. Koomen, Reginald M Atkins, Doris K Hansen, Ariosto Siqueira Silva, Jongphil Kim, Yoganand Balagurunathan, and Frederick L Locke.

Ciara Freeman

Ariel Grajales-Cruz Ariosto Siqueira Silva BCMA Blood Journal Brandon J Blue cancer Ciara Freeman Ciara L. Freeman Dietrich Werner Idiaquez Doris K. Hansen Eric C Smith Frederick L. Locke Gabriel De Avila Hien D Liu Jerald Noble John M. Koomen Jongphil Kim Julieta Abraham-Miranda Justyn Y Nakashima Kenneth H Shain Lawrence Skelson Meghan Menges Melissa Alsina Nicholas B Figura Omar Castaneda Puglianini OncoDaily Oncology R. Petter Tonseth Rachid C Baz Reginald M Atkins Ricardo Villanueva Salvatore Corallo Taiga Nishihori tumor burden Yoganand Balagurunathan
Special Coverage
Insight
May 29, 2025, 21:57
European School of Oncology: Apply for Basics in Breast Cancer Surgery course by June 29
Opinion
May 29, 2025, 21:49
Association of European Cancer Leagues Shared a New Position Paper on PFAS free future
Opinion
May 29, 2025, 21:41
To Record or Not to Record – Olumide Ofinran on Patient Requests During Cancer Diagnosis Consultations
Blog
May 29, 2025, 21:35
Toufic Kachaamy: Are the rich, famous and powerful treated differently when it comes to cancer screening?
Career
May 29, 2025, 21:29
Sendurai Mani: Honored to Receive the Master of Arts Degree from Brown University
Blog
May 29, 2025, 21:17
SPCC on Interview with Aleksandra Filipovic and Ellen Langer About Scientifically Proven Connection Between Mindset and Health
Blog
May 29, 2025, 21:09
Sebastian Szmit: Great Pleasure to Work in SERENITY Study by European Commission
Blog
May 29, 2025, 20:53
Jasmine Kamboj Congratulated Jonathan Ticku for FDA ODAC Testimony on Daratumumab
Opinion
May 29, 2025, 20:33
Zainab Shinkafi-Bagudu Reflects on Access, Staffing, and Policy Ahead of AMCE Launch in Nigeria
Blog
May 29, 2025, 19:20
Diego A. Díaz García: sq-NSCLC Data Shows Benmelstobart Plus Chemo as Promising New 1L Option
Positive
May 29, 2025, 19:09
Excited to Announce the 2025 Board of Directors - IASLC
Career
May 29, 2025, 19:02
Vincent Rajkumar: Thrilled Saad Usmani Will Receive the Giants of Cancer Care Award for Myeloma